» Articles » PMID: 16651008

Reliability of MRI-derived Measurements of Human Cerebral Cortical Thickness: the Effects of Field Strength, Scanner Upgrade and Manufacturer

Overview
Journal Neuroimage
Specialty Radiology
Date 2006 May 3
PMID 16651008
Citations 789
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo MRI-derived measurements of human cerebral cortex thickness are providing novel insights into normal and abnormal neuroanatomy, but little is known about their reliability. We investigated how the reliability of cortical thickness measurements is affected by MRI instrument-related factors, including scanner field strength, manufacturer, upgrade and pulse sequence. Several data processing factors were also studied. Two test-retest data sets were analyzed: 1) 15 healthy older subjects scanned four times at 2-week intervals on three scanners; 2) 5 subjects scanned before and after a major scanner upgrade. Within-scanner variability of global cortical thickness measurements was <0.03 mm, and the point-wise standard deviation of measurement error was approximately 0.12 mm. Variability was 0.15 mm and 0.17 mm in average, respectively, for cross-scanner (Siemens/GE) and cross-field strength (1.5 T/3 T) comparisons. Scanner upgrade did not increase variability nor introduce bias. Measurements across field strength, however, were slightly biased (thicker at 3 T). The number of (single vs. multiple averaged) acquisitions had a negligible effect on reliability, but the use of a different pulse sequence had a larger impact, as did different parameters employed in data processing. Sample size estimates indicate that regional cortical thickness difference of 0.2 mm between two different groups could be identified with as few as 7 subjects per group, and a difference of 0.1 mm could be detected with 26 subjects per group. These results demonstrate that MRI-derived cortical thickness measures are highly reliable when MRI instrument and data processing factors are controlled but that it is important to consider these factors in the design of multi-site or longitudinal studies, such as clinical drug trials.

Citing Articles

Subcortical Gray Matter Volume Abnormalities in Temporal Lobe Epilepsy with Hippocampal Atrophy.

Dos Santos G, Ono S, de Carvalho Neto A, de Paola L, Silvado C, Marques G Clin Med Res. 2025; 22(4):180-187.

PMID: 39993832 PMC: 11849968. DOI: 10.3121/cmr.2024.1894.


Amygdala Nuclei Atrophy in Cognitive Impairment and Dementia: Insights from High-Resolution Magnetic Resonance Imaging.

Peiseniece E, Zdanovskis N, Sneidere K, Kostiks A, Karelis G, Platkajis A Medicina (Kaunas). 2025; 61(1).

PMID: 39859112 PMC: 11766737. DOI: 10.3390/medicina61010130.


Bridging animal models and humans: neuroimaging as intermediate phenotypes linking genetic or stress factors to anhedonia.

Guo H, Xiao Y, Dong S, Yang J, Zhao P, Zhao T BMC Med. 2025; 23(1):38.

PMID: 39849528 PMC: 11755933. DOI: 10.1186/s12916-025-03850-4.


Basolateral amygdala volume in affective disorders using 7T MRI .

Kurzinger B, Schindler S, Meffert M, Rosenhahn A, Trampel R, Turner R Front Psychiatry. 2025; 15():1404594.

PMID: 39834577 PMC: 11744004. DOI: 10.3389/fpsyt.2024.1404594.


Advancements in Frank's sign Identification using deep learning on 3D brain MRI.

Jo S, Kim J, Kwon M, Park J, Kim J, Jhoo J Sci Rep. 2025; 15(1):2383.

PMID: 39827273 PMC: 11743131. DOI: 10.1038/s41598-024-82756-2.